The development of α-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma
- 1 April 1989
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 160 (4) , 789-797
- https://doi.org/10.1016/0002-9378(89)90293-7
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- An improved generator for the production of 212Pb and 212Bi from 224RaApplied Radiation and Isotopes, 1988
- Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.Proceedings of the National Academy of Sciences, 1986
- 211At radiocolloid therapy: Further observations and comparison with radiocolloids of 32P, 165Dy, and 90YInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Astatine-211—Tellurium Radiocolloid Cures Experimental Malignant AscitesScience, 1981
- Radiocolloids in the Treatment of Ovarian CancerObstetrical & Gynecological Survey, 1979